Nothing in that report that we didn't already know about beforehand.
At the end of the day if SBL and the USA is not a going concern for us then why not close SBL down, move the membrane manufacturing to SiYi, let ED manufacture or outsource Oraline 8 ?
Sell Visualine to Bioscreens and any other IP of value.
Overheads would then be minimal and China is still on track.
Makes sense doesn't it ?
notice received, page-13
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)